Skip to main content
Fig. 3 | Cardio-Oncology

Fig. 3

From: Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients

Fig. 3

Plasma metabolite dysregulation in left ventricular dysfunction. A Principal component analysis of all significant metabolites combined. B Schematic of differentially expressed metabolites (red) converging to the glutamate synthesis pathway. C Overall top differentially expressed metabolites in LVD (n = 10) versus control patients (n = 40). D, E Sex-specific differentially expressed metabolites in males (control = 16, LVD = 6, D) and females (control = 22, LVD = 4, E)

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us